Andres Maldonado
Stock Analyst at HC Wainwright & Co.
(3.72)
# 707
Out of 5,182 analysts
62
Total ratings
52%
Success rate
51.92%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andres Maldonado
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AURA Aura Biosciences | Assumes: Buy | $22 | $6.96 | +216.09% | 1 | May 28, 2025 | |
| ZNTL Zentalis Pharmaceuticals | Reiterates: Buy | $10 | $4.25 | +135.29% | 1 | May 15, 2025 | |
| CRBP Corbus Pharmaceuticals Holdings | Maintains: Buy | $50 → $40 | $10.08 | +296.83% | 2 | May 7, 2025 | |
| TCRX TScan Therapeutics | Maintains: Buy | $15 → $10 | $1.31 | +663.36% | 1 | May 7, 2025 | |
| ERAS Erasca | Reiterates: Buy | $6 | $19.15 | -68.67% | 10 | Apr 30, 2025 | |
| FHTX Foghorn Therapeutics | Reiterates: Buy | $13 | $5.21 | +149.52% | 1 | Apr 30, 2025 | |
| STRO Sutro Biopharma | Reiterates: Neutral | $20 | $33.59 | -40.46% | 1 | Apr 29, 2025 | |
| TARA Protara Therapeutics | Reiterates: Buy | $23 | $4.99 | +360.92% | 1 | Apr 28, 2025 | |
| CGON CG Oncology | Reiterates: Buy | $75 | $66.82 | +12.24% | 13 | Apr 28, 2025 | |
| HOWL Werewolf Therapeutics | Reiterates: Buy | $15 | $0.83 | +1,707.23% | 16 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $7.20 | +247.22% | 2 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $50 | $46.29 | +8.01% | 13 | Nov 26, 2024 |
Aura Biosciences
May 28, 2025
Assumes: Buy
Price Target: $22
Current: $6.96
Upside: +216.09%
Zentalis Pharmaceuticals
May 15, 2025
Reiterates: Buy
Price Target: $10
Current: $4.25
Upside: +135.29%
Corbus Pharmaceuticals Holdings
May 7, 2025
Maintains: Buy
Price Target: $50 → $40
Current: $10.08
Upside: +296.83%
TScan Therapeutics
May 7, 2025
Maintains: Buy
Price Target: $15 → $10
Current: $1.31
Upside: +663.36%
Erasca
Apr 30, 2025
Reiterates: Buy
Price Target: $6
Current: $19.15
Upside: -68.67%
Foghorn Therapeutics
Apr 30, 2025
Reiterates: Buy
Price Target: $13
Current: $5.21
Upside: +149.52%
Sutro Biopharma
Apr 29, 2025
Reiterates: Neutral
Price Target: $20
Current: $33.59
Upside: -40.46%
Protara Therapeutics
Apr 28, 2025
Reiterates: Buy
Price Target: $23
Current: $4.99
Upside: +360.92%
CG Oncology
Apr 28, 2025
Reiterates: Buy
Price Target: $75
Current: $66.82
Upside: +12.24%
Werewolf Therapeutics
Mar 12, 2025
Reiterates: Buy
Price Target: $15
Current: $0.83
Upside: +1,707.23%
Mar 11, 2025
Reiterates: Buy
Price Target: $25
Current: $7.20
Upside: +247.22%
Nov 26, 2024
Maintains: Buy
Price Target: $40 → $50
Current: $46.29
Upside: +8.01%